NL-OMON20237招募中不适用
Irreversible electroporation treatMent in patients with PAncreatic Locally advanced Adenocarcinoma: a phase II safety study
AMC Amsterdam0 个研究点目标入组 106 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 106
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age 18 years or older
- •Capable of providing written and oral informed consent
排除标准
- •Resectable pancreatic cancer during explorative laparotomy
- •Presence of metastatic disease (peritoneal, liver or other)
研究者
相似试验
已完成
2 期
Irreversible electroporation treatment in patients with pancreatic locally advanced adenocarcinomaPancreatic adenocarcinoma100179901001799110017998Pancreatic CancerNL-OMON40224Academisch Medisch Centrum50
尚未招募
不适用
Irreversible Electroporation for treatment of unresectable, locally advanced pancreatic cancer in the Leiden University Medical Center: a phase I/II studyocally advanced unresectable pancreatic cancer, alvleesklierkanker, lokaal uitgebreidNL-OMON21164eiden University Medical Centre15
招募中
2 期
Irreversible Electroporation for treatment of unresectable, locally advanced pancreatic cancer in the Leiden University Medical Centre: a phase I/II study.pancreatic cancercarcinoma of the pancreas1001981510019818NL-OMON40396eids Universitair Medisch Centrum15
已完成
不适用
Irreversible Electroporation (IRE) for the treatment of focal liver, kidney and lung cancer ablation: a pilot studyFocal tumours of the liverFocal tumours of the lungFocal tumours of the kidneyCancer - KidneyCancer - LiverCancer - Lung - Small cellACTRN12611000937910The Alfred Hospital40
终止
2 期
Irreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic CancerPancreas CancerNCT05435053Ismail Gögenur9